Hsa-miR-100-5p promotes the development and progression of gastric cancer through targeted atypical chemokine receptor 3

Collectively, these results indicate that hsa-miR-100-5p may regulate <i>ACKR3</i> to enhance the migration and proliferation of GC cells, thereby contributing to the onset and progression of gastric cancer.

Authors

Institutions

Publication Details

Journal
International Journal of Clinical and Experimental Pathology
Published
2025-01-01
DOI
https://doi.org/10.62347/sbgt4820
Primary Topic
MicroRNA in disease regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hsa-miR-100-5p promotes the development and progression of gastric cancer through targeted atypical chemokine receptor 3

Xiaoli Wang
International Journal of Clinical and Experimental Pathology
MicroRNA in disease regulation
article

Hsa-miR-100-5p promotes the development and progression of gastric cancer through targeted atypical chemokine receptor 3

Xiaoli Wang
article en

Abstract

Collectively, these results indicate that hsa-miR-100-5p may regulate <i>ACKR3</i> to enhance the migration and proliferation of GC cells, thereby contributing to the onset and progression of gastric cancer.

International Journal of Clinical and Experimental PathologyVol. 18(7)
Nantong Tumor Hospital (CN)
Good health and well-being
Openalex Percentile: Top 76%
MicroRNA in disease regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Hsa-miR-100-5p promotes the development and progression of gastric cancer through targeted atypical chemokine receptor 3 — Xiaoli Wang · International Journal of Clinical and Experimental Pathology (2025) | TGRS Research Map | TGRS